MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jcin.2026.04.034

Медицинская библиотека · JACC. Cardiovascular interventions · 2026

BenchTop Validation of UNICORN Leaflet Modification Technique in Redo-Transcatheter Aortic Valve Replacement.

Lam Simon Cheung-Chi, Chiu Ho-On Alston Conrad, Chan Kwong-Yue Eric, Chan Daniel Tai-Leung, Lee Yee-Tat, Lin Pei, Sze Shu-Yue, Lee Cheuk-Wing, Shek Joyce, Tam Frankie Chor-Cheung, Wong Max Kwun-Hung, Yin Wei-Hsian, Lee Yung-Tsai, Poon Karl, Tang Gilbert H L, Un Ka-Chun, Wong Chun-Ka

СтатьяВалидационное исследованиеСравнительное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Coronary obstruction is a critical risk in valve-in-valve transcatheter aortic valve replacement (TAVR). The UNICORN (undermining iatrogenic coronary obstruction with radiofrequency needle) technique mitigates this risk via intraleaflet valve deployment. However, comprehensive bench testing data regarding this technique is lacking in the literature.

OBJECTIVES

The aims of this study were to evaluate leaflet behavior after intraleaflet balloon dilatation across different transcatheter heart valve (THV) platforms, simulate the crossing of a second THV across de novo fenestrations, and understand leaflet behavior during and after deployment.

METHODS

In vitro bench testing used 4 index THV platforms: SAPIEN 3, Evolut, Navitor, and ACURATE neo2. Following leaflet traversal, target leaflets underwent sequential balloon dilatation (8-14 mm). We assessed the maximum balloon size tolerated without laceration, the minimum size required for a second balloon-expandable THV (SAPIEN 3 Ultra RESILIA) to cross the fenestration, deployment feasibility, and postdeployment valve geometry.

RESULTS

Most index THV leaflets tolerated balloon dilatation up to 12 to 14 mm without laceration. A minimum fenestration size of 12 to 14 mm facilitated most of the second THV crossing. Postdeployment models confirmed coronary clearance on the treated side. Successful intraleaflet THV deployment was achieved with the SAPIEN 3, Evolut, and ACURATE neo2. Conversely, intraleaflet deployment in the Navitor (and Portico) platform was unsuccessful; the leaflet remained intact following expansion, resulting in frame distortion and inner-valve tilting possibly due to stiff leaflet and compliant frame.

CONCLUSIONS

This bench study defines optimal balloon sizing for UNICORN across common THV platforms and confirms coronary clearance. It was determined that one index valve resisted intraleaflet deployment. Further clinical validation is required before widespread adoption.

Для цитирования: Lam Simon Cheung-Chi, Chiu Ho-On Alston Conrad, Chan Kwong-Yue Eric, Chan Daniel Tai-Leung, Lee Yee-Tat, Lin Pei, Sze Shu-Yue, Lee Cheuk-Wing, Shek Joyce, Tam Frankie Chor-Cheung, Wong Max Kwun-Hung, Yin Wei-Hsian, Lee Yung-Tsai, Poon Karl, Tang Gilbert H L, Un Ka-Chun, Wong Chun-Ka. BenchTop Validation of UNICORN Leaflet Modification Technique in Redo-Transcatheter Aortic Valve Replacement.. JACC. Cardiovascular interventions. 2026. DOI: 10.1016/j.jcin.2026.04.034.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.